Health-care companies rose amid deal activity.
Baxter International is in advanced talks to buy medical-equipment maker Hill-Rom Holdings for around $10 billion, The Wall Street Journal reported.
Contract drug manufacturer Catalent agreed to buy closely held nutritional supplement maker Bettera Holdings for $1 billion.
Pfizer's recent acquisition of Trillium Therapeutics, meanwhile, reflects Big Pharma's appetite for biotech companies, according to an analysis from The Wall Street Journal.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
08-30-21 1703ET
